Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jun 22:148:e124.
doi: 10.1017/S0950268820001351.

Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas

M O Enzmann  1 , M P Erickson  1 , C J Grindeland  1 , S M C Lopez  2 , S E Hoover  2 , D D Leedahl  1
Affiliations
Multicenter Study

Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas

M O Enzmann et al. Epidemiol Infect. .

Abstract

The majority of available US-published reports present populations with community spread in urban areas. The objective of this report is to describe a rural healthcare system's utilisation of therapeutic options available to treat Coronavirus Disease 2019 (COVID-19) and subsequent patient outcomes. A total of 150 patients were treated for COVID-19 at three hospitals in the Dakotas from 21 March 2020 to 30 April 2020. The most common pharmacological treatment regimens administered were zinc, hydroxychloroquine plus azithromycin and convalescent plasma. Adjunctive treatments included therapeutic anticoagulation, tocilizumab and corticosteroids. As of 1 June 2020, 127 patients have survived to hospital discharge, 12 patients remain hospitalised and 11 patients have expired. The efficacy of hydroxychloroquine and azithromycin use has yet to be determined but was not without risks of corrected QT interval prolongation and arrhythmias in our cohort. We did not appreciate any adverse effects that appeared related to tocilizumab or convalescent plasma administration in those patient subsets. These findings may provide insight into disease severity and treatment options in the rural setting with limited resources to participate in clinical trials and encourage larger comparative studies evaluating treatment efficacy.

Keywords: COVID-19; Coronavirus; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Coronavirus disease (COVID-19) outbreak situation (2020) World Health Organization. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Updated 5 April 2020 (Accessed 6 April 2020).
    1. COVID-19 projections assuming full social distancing through August 1, 2020. Institute for Health Metrics and Evaluation. Available at https://covid19.healthdata.org Updated 10 May 2020 (Accessed 12 May 2020).
    1. Bhatraju PK et al. (2020) Covid-19 in critically ill patients in the Seattle Region – case series. New England Journal of Medicine 382(21), 2012–2022. doi: 10.1056/NEJMoa2004500. - DOI - PMC - PubMed
    1. Spellberg B et al. (2020) Community prevalence of SARS-CoV-2 among patients with influenza-like illnesses presenting to a Los Angeles Medical Center in March 2020. Journal of the American Medical Association 323(19), 1966–1967. doi: 10.1001/jama.2020.4958. - DOI - PMC - PubMed
    1. Midwest information office (2020) U.S. Bureau of Labor Statistics. https://www.bls.gov/regions/midwest Updated 2 June 2020 (Accessed 2 June 2020).

Publication types

MeSH terms